<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7152899\results\search\disease\results.xml">
  <result pre="as long as the COVID-19 resource centre remains active. Viral" exact="hepatitis" post="can cause a wide spectrum of clinical presentations from"/>
  <result pre="latter more likely leading to chronic infection. Management of chronic" exact="hepatitis" post="D virus is individualized because of the paucity of"/>
  <result pre="side effect profile of currently available treatments. Sporadic cases of" exact="hepatitis" post="E caused by contaminated meats are becoming increasingly prevalent"/>
  <result pre="Keywords Hepatitis D Hepatitis E Hepatotropic viruses Human herpesvirus Viral" exact="hepatitis" post="Key points •Hepatitis D virus (HDV) requires hepatitis B"/>
  <result pre="herpesvirus Viral hepatitis Key points •Hepatitis D virus (HDV) requires" exact="hepatitis" post="B virus for replication and is more likely to"/>
  <result pre="cause chronic infection in the setting of HDV superinfection in" exact="hepatitis" post="B surface antigen–positive individuals. Treatment of HDV remains limited,"/>
  <result pre="significant morbidity and mortality in immunocompromised hosts. Introduction The term" exact="viral hepatitis" post="refers to liver inflammation that occurs because of a"/>
  <result pre="morbidity and mortality in immunocompromised hosts. Introduction The term viral" exact="hepatitis" post="refers to liver inflammation that occurs because of a"/>
  <result pre="C, D, and E) that selectively infect the liver. Acute" exact="hepatitis" post="caused by these viruses may resolve without intervention or"/>
  <result pre="described in 1977 in a group of patients infected with" exact="hepatitis" post="B virus (HBV) who were found to have more"/>
  <result pre="B virus (HBV) who were found to have more severe" exact="hepatitis" post="than their counterparts.1 The hepatitis D virion consists of"/>
  <result pre="found to have more severe hepatitis than their counterparts.1 The" exact="hepatitis" post="D virion consists of the hepatitis D RNA genome,"/>
  <result pre="than their counterparts.1 The hepatitis D virion consists of the" exact="hepatitis" post="D RNA genome, hepatitis D antigen (HDAg), and a"/>
  <result pre="hepatitis D virion consists of the hepatitis D RNA genome," exact="hepatitis" post="D antigen (HDAg), and a lipoprotein envelope containing HBV"/>
  <result pre="virion assembly and export. Since the widespread availability of the" exact="hepatitis" post="B vaccine with worldwide implementation of vaccination programs, a"/>
  <result pre="nearly 1% of the general population.4 Clinical Presentation Infection with" exact="hepatitis" post="D can occur under 2 circumstances (Fig. 1 )."/>
  <result pre="). Coinfection occurs when an individual is exposed to both" exact="hepatitis" post="B and D viruses simultaneously with a similar presentation"/>
  <result pre="failure (ALF). Superinfection occurs when an individual with established chronic" exact="hepatitis" post="B infection (defined by the presence of HBsAg) is"/>
  <result pre="by the presence of HBsAg) is exposed to an acute" exact="hepatitis" post="D infection. Although superinfection with HDV is more likely"/>
  <result pre="clearance.5 Chronic HDV infection is the most aggressive form of" exact="viral hepatitis" post="with greater rates of hepatocellular carcinoma and more rapid"/>
  <result pre="Chronic HDV infection is the most aggressive form of viral" exact="hepatitis" post="with greater rates of hepatocellular carcinoma and more rapid"/>
  <result pre="most aggressive form of viral hepatitis with greater rates of" exact="hepatocellular carcinoma" post="and more rapid progression to cirrhosis compared with HBV"/>
  <result pre="greater rates of hepatocellular carcinoma and more rapid progression to" exact="cirrhosis" post="compared with HBV monoinfection.6, 7, 8, 9 Fig. 1"/>
  <result pre="HBV infection most often leads to chronic HDV infection. HBcAb," exact="hepatitis" post="B core antibody; HBsAb, hepatitis B surface antibody; IgG,"/>
  <result pre="to chronic HDV infection. HBcAb, hepatitis B core antibody; HBsAb," exact="hepatitis" post="B surface antibody; IgG, immunoglobulin G; IgM, immunoglobulin M."/>
  <result pre="more of the following risk factors10: •Individuals with HIV or" exact="hepatitis" post="C virus (HCV) coinfection •Current or past intravenous drug"/>
  <result pre="HDV infection but an undetected RNA level.14Table 1 Serologies in" exact="hepatitis" post="B virus and hepatitis D virus infection HBsAg Anti-HBc"/>
  <result pre="undetected RNA level.14Table 1 Serologies in hepatitis B virus and" exact="hepatitis" post="D virus infection HBsAg Anti-HBc IgM Anti-HBc IgG HBV"/>
  <result pre="− − + − − − + − Abbreviations: anti-HBc," exact="hepatitis" post="B core antibody; HDAg, hepatitis D antigen; anti-HDV, hepatitis"/>
  <result pre="− + − Abbreviations: anti-HBc, hepatitis B core antibody; HDAg," exact="hepatitis" post="D antigen; anti-HDV, hepatitis D antibody; IgG, immunoglobulin G;"/>
  <result pre="anti-HBc, hepatitis B core antibody; HDAg, hepatitis D antigen; anti-HDV," exact="hepatitis" post="D antibody; IgG, immunoglobulin G; IgM, immunoglobulin M. aMay"/>
  <result pre="infection. The goal of HDV therapy is to achieve viral" exact="suppression" post="with sustained clearance of HDV after treatment completion. Thus"/>
  <result pre="DNA levels greater than 2000 IU/mL and all patients with" exact="cirrhosis" post="regardless of HBV replication status (Table 2 ). Table"/>
  <result pre="status (Table 2 ). Table 2 Treatment recommendations in chronic" exact="hepatitis" post="B virus and hepatitis D virus coinfection HDV RNA"/>
  <result pre="Table 2 Treatment recommendations in chronic hepatitis B virus and" exact="hepatitis" post="D virus coinfection HDV RNA ALT HBV DNA Cirrhosis"/>
  <result pre="with all patients with cirrhosis, ongoing screening is needed for" exact="esophageal varices" post="and hepatocellular carcinoma. For patients who undergo liver transplant,"/>
  <result pre="with cirrhosis, ongoing screening is needed for esophageal varices and" exact="hepatocellular carcinoma." post="For patients who undergo liver transplant, hepatitis B immune"/>
  <result pre="varices and hepatocellular carcinoma. For patients who undergo liver transplant," exact="hepatitis" post="B immune globulin is administered similar to patients with"/>
  <result pre="E virus (HEV) is the most common cause of acute" exact="viral hepatitis" post="worldwide. The original hepatitis E outbreak likely occurred in"/>
  <result pre="virus (HEV) is the most common cause of acute viral" exact="hepatitis" post="worldwide. The original hepatitis E outbreak likely occurred in"/>
  <result pre="most common cause of acute viral hepatitis worldwide. The original" exact="hepatitis" post="E outbreak likely occurred in New Delhi in 1955,"/>
  <result pre="was initially isolated from the stool of Soviet soldiers experiencing" exact="hepatitis" post="outbreaks during the military conflict in Afghanistan during the"/>
  <result pre="HEV was subsequently named in 1990 to distinguish it from" exact="hepatitis" post="A virus, an additional source of waterborne hepatitis epidemics"/>
  <result pre="it from hepatitis A virus, an additional source of waterborne" exact="hepatitis" post="epidemics at the time.29 There are 4 known HEV"/>
  <result pre="are either asymptomatic or have a self-limited course of acute" exact="hepatitis" post="with nonspecific symptoms and spontaneous resolution after 4 to"/>
  <result pre="of acute-on-chronic liver failure worldwide.34 Chronic HEV, defined by chronic" exact="hepatitis" post="with increased aminotransferase levels and persistent detection of HEV"/>
  <result pre="Extrahepatic Manifestations Neurologic: Guillain-Barré syndrome, radiculoneuropathy, amyotrophy, encephalitisRenal: membranous and" exact="membranoproliferative glomerulonephritis," post="IgA nephropathyHematologic: aplastic anemia, autoimmune hemolytic anemia, cryoglobulinemia, thrombocytopeniaPancreatic:"/>
  <result pre="syndrome, radiculoneuropathy, amyotrophy, encephalitisRenal: membranous and membranoproliferative glomerulonephritis, IgA nephropathyHematologic:" exact="aplastic anemia," post="autoimmune hemolytic anemia, cryoglobulinemia, thrombocytopeniaPancreatic: pancreatitisRheumatologic: polyarthritisCardiac: myocarditisEndocrine: thyroiditis"/>
  <result pre="amyotrophy, encephalitisRenal: membranous and membranoproliferative glomerulonephritis, IgA nephropathyHematologic: aplastic anemia," exact="autoimmune hemolytic anemia," post="cryoglobulinemia, thrombocytopeniaPancreatic: pancreatitisRheumatologic: polyarthritisCardiac: myocarditisEndocrine: thyroiditis Diagnosis Serologies HEV"/>
  <result pre="encephalitisRenal: membranous and membranoproliferative glomerulonephritis, IgA nephropathyHematologic: aplastic anemia, autoimmune" exact="hemolytic anemia," post="cryoglobulinemia, thrombocytopeniaPancreatic: pancreatitisRheumatologic: polyarthritisCardiac: myocarditisEndocrine: thyroiditis Diagnosis Serologies HEV"/>
  <result pre="aplastic anemia, autoimmune hemolytic anemia, cryoglobulinemia, thrombocytopeniaPancreatic: pancreatitisRheumatologic: polyarthritisCardiac: myocarditisEndocrine:" exact="thyroiditis" post="Diagnosis Serologies HEV IgM and/or HEV RNA HEV RNA"/>
  <result pre="Varies: minimal inflammation, mild acute cellular rejection Differential Diagnoses Acute" exact="viral hepatitis" post="(HAV, HBV, HCV, HEV, CMV, EBV)Autoimmune hepatitisDrug-induced liver injury"/>
  <result pre="minimal inflammation, mild acute cellular rejection Differential Diagnoses Acute viral" exact="hepatitis" post="(HAV, HBV, HCV, HEV, CMV, EBV)Autoimmune hepatitisDrug-induced liver injury"/>
  <result pre="(liver transplant patients)Graft-versus-host disease (SOT or SCT patients)Drug-induced liver injuryChronic" exact="viral hepatitis" post="(HBV, HCV, HDV)EBV and CMV hepatitis (reactivation) Treatment NoneConsider"/>
  <result pre="transplant patients)Graft-versus-host disease (SOT or SCT patients)Drug-induced liver injuryChronic viral" exact="hepatitis" post="(HBV, HCV, HDV)EBV and CMV hepatitis (reactivation) Treatment NoneConsider"/>
  <result pre="patients)Drug-induced liver injuryChronic viral hepatitis (HBV, HCV, HDV)EBV and CMV" exact="hepatitis" post="(reactivation) Treatment NoneConsider treatment if extrahepatic manifestations or high"/>
  <result pre="treatment if extrahepatic manifestations or high risk; ie, pregnancy, chronic" exact="liver disease" post="Reduction of immunosuppression (avoidance of calcineurin inhibitors)Ribavirin 600 mg"/>
  <result pre="in most countries) Abbreviations: CMV, cytomegalovirus; EBV, Epstein-Barr virus; HAV," exact="hepatitis" post="A virus; HCV, hepatitis C virus; IgA, immunoglobulin A;"/>
  <result pre="CMV, cytomegalovirus; EBV, Epstein-Barr virus; HAV, hepatitis A virus; HCV," exact="hepatitis" post="C virus; IgA, immunoglobulin A; SOT, solid organ transplant;"/>
  <result pre="apoptotic bodies, which may have similar overlapping features with other" exact="viral hepatitis," post="autoimmune hepatitis, or drug-induced liver injury.46 Because most cases"/>
  <result pre="which may have similar overlapping features with other viral hepatitis," exact="autoimmune hepatitis," post="or drug-induced liver injury.46 Because most cases of acute"/>
  <result pre="tested in transplant recipients if a liver biopsy shows chronic" exact="hepatitis" post="of uncertain cause or a nondiagnostic biopsy in the"/>
  <result pre="of rapamycin inhibitors.50 Interferon has been used for treatment of" exact="hepatitis" post="B and C, so it has similarly been investigated"/>
  <result pre="relapse after treatment.52 There is currently 1 licensed vaccine for" exact="hepatitis" post="E (HEV 239, Hecolin) available in China, which is"/>
  <result pre="the Herpesviridae family that can cause disease in humans, including" exact="viral hepatitis" post="(Table 4 ). Initial infections with these viruses are"/>
  <result pre="Herpesviridae family that can cause disease in humans, including viral" exact="hepatitis" post="(Table 4 ). Initial infections with these viruses are"/>
  <result pre="Hostsc Liver Histology HHV-1 HSV-1 Oral and genital ulcers ALF," exact="encephalitis" post="Hepatocyte necrosis, intranuclear inclusions, multinucleated giant cells HHV-2 HSV-2"/>
  <result pre="multinucleated giant cells HHV-2 HSV-2 Oral and genital ulcers ALF," exact="encephalitis" post="Hepatocyte necrosis, intranuclear inclusions, multinucleated giant cells HHV-3 VZV"/>
  <result pre="intranuclear inclusions, multinucleated giant cells HHV-3 VZV Chickenpox, shingles ALF," exact="encephalitis" post="Hepatocyte necrosis, intranuclear inclusions, multinucleated giant cells HHV-4 EBV"/>
  <result pre="inclusions, multinucleated giant cells HHV-4 EBV Infectious mononucleosisa Hepatitis, PTLD," exact="lymphoma" post="Sinusoidal lymphocytic infiltration HHV-5 CMV Mononucleosislike syndromea Multisystemic organ"/>
  <result pre="Nonspecific HHV-7 Pityriasis rosea Rare Nonspecific HHV-8 KSHV Fever, rash," exact="lymphadenopathy" post="Kaposi sarcoma, Castleman disease Proliferation of spindle-shaped cells Abbreviations:"/>
  <result pre="Abbreviations: CMV, cytomegalovirus; EBV, Epstein-Barr virus; HHV, human herpesvirus; HSV," exact="herpes simplex" post="virus; KSHV, Kaposi sarcoma–associated herpes virus; PTLD, posttransplant lymphoproliferative"/>
  <result pre="and lymphadenopathy. bHepatitis, pneumonitis, colitis, myocarditis, retinitis, encephalitis, cytopenias. cMild" exact="hepatitis" post="may occur with all HHV infections but severe hepatitis"/>
  <result pre="cMild hepatitis may occur with all HHV infections but severe" exact="hepatitis" post="and ALF typically only occur in immunocompromised hosts. Herpes"/>
  <result pre="Virus Varicella zoster virus (VZV) is commonly known for causing" exact="chickenpox" post="in children at the time of initial infection, and"/>
  <result pre="secretions or direct contact with fluid from vesicular lesions. VZV-associated" exact="hepatitis" post="has been rarely reported in the literature but can"/>
  <result pre="Virus Epstein-Barr virus (EBV) is a common infection that causes" exact="infectious mononucleosis" post="with fevers, pharyngitis, and lymphadenopathy. More than 90% of"/>
  <result pre="by 20 years of age.59 Unlike the other herpesviruses, mild" exact="hepatitis" post="with hepatomegaly and increased transaminase level typically occurs with"/>
  <result pre="to identify the presence of virus, although confirmation of EBV-related" exact="hepatitis" post="also requires the appropriate clinical features, including increased transaminase"/>
  <result pre="antigen antibody and EBV DNA).62 Virtually all cases of EBV" exact="hepatitis" post="are self-limited, but rare cases of severe hepatitis or"/>
  <result pre="of EBV hepatitis are self-limited, but rare cases of severe" exact="hepatitis" post="or ALF may require liver transplant. EBV infection after"/>
  <result pre="within the first year of transplant.67 In these cases, CMV" exact="hepatitis" post="may be difficult to differentiate from graft rejection. CMV"/>
  <result pre="valganciclovir or intravenous ganciclovir may be used to treat CMV" exact="hepatitis" post="depending on the severity of illness. Human Herpes Viruses"/>
  <result pre="are typically subclinical infections that may present as roseola or" exact="pityriasis rosea," post="respectively. Reactivation in transplant recipients has been reported to"/>
  <result pre="of Kaposi sarcoma, lymphoma, and multicentric Castleman disease. Although Kaposi" exact="sarcoma" post="is more commonly reported in association with acquired immunodeficiency"/>
  <result pre="a range of clinical presentations, from mild to severe acute" exact="hepatitis" post="and ALF, including:72 •Adenoviridae •Arenaviridae: Lassa virus •Coronaviridae: severe"/>
  <result pre="acute hepatitis and ALF, including:72 •Adenoviridae •Arenaviridae: Lassa virus •Coronaviridae:" exact="severe acute respiratory syndrome" post="virus •Filoviridae: Ebola virus •Flaviviridae: Dengue virus, West Nile"/>
  <result pre="virus •Filoviridae: Ebola virus •Flaviviridae: Dengue virus, West Nile virus," exact="yellow fever" post="virus, Zika virus •Orthomyxoviridae: influenza virus •Paramyxoviridae: measles morbillivirus"/>
  <result pre="virus, West Nile virus, yellow fever virus, Zika virus •Orthomyxoviridae:" exact="influenza" post="virus •Paramyxoviridae: measles morbillivirus •Parvoviridae: parvovirus B19 •Picornaviridae: Coxsackie"/>
  <result pre="virus, yellow fever virus, Zika virus •Orthomyxoviridae: influenza virus •Paramyxoviridae:" exact="measles" post="morbillivirus •Parvoviridae: parvovirus B19 •Picornaviridae: Coxsackie virus, echovirus, poliovirus"/>
  <result pre="parvovirus B19 •Picornaviridae: Coxsackie virus, echovirus, poliovirus •Retroviridae: HIV •Togaviridae:" exact="chikungunya" post="virus Summary Both HDV and HEV are causes of"/>
  <result pre="to chronic disease after superinfection with an accelerated course to" exact="cirrhosis" post="or related complications. HEV leading to chronic hepatitis is"/>
  <result pre="course to cirrhosis or related complications. HEV leading to chronic" exact="hepatitis" post="is more common in immunocompromised hosts. Although the hepatotropic"/>
  <result pre="CMV) typically have self-limited courses that may include a mild" exact="hepatitis" post="caused by the immune system’s response to the virus"/>
  <result pre="References 1RizzettoM.CaneseM.G.AricòS.Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to" exact="hepatitis" post="B virus in liver and in serum of HBsAg"/>
  <result pre="and Boyer's hepatology: a textbook of liver disease7th edition2018ElsevierPhiladelphia501511 3LinH.H.LeeS.S.YuM.L.Changing" exact="hepatitis" post="D virus epidemiology in a hepatitis B virus endemic"/>
  <result pre="liver disease7th edition2018ElsevierPhiladelphia501511 3LinH.H.LeeS.S.YuM.L.Changing hepatitis D virus epidemiology in a" exact="hepatitis" post="B virus endemic area with a national vaccination programHepatology61620151870187925677884"/>
  <result pre="area with a national vaccination programHepatology61620151870187925677884 4ChenH.Y.ShenD.JiD.Prevalence and burden of" exact="hepatitis" post="D virus infection in the global population: a systematic"/>
  <result pre="agent: indistinguishable disease with different outcomeJ Infect Dis151519859259283989325 6FattovichG.BoscaroS.NoventaF.Influence of" exact="hepatitis" post="delta virus infection on progression to cirrhosis in chronic"/>
  <result pre="Dis151519859259283989325 6FattovichG.BoscaroS.NoventaF.Influence of hepatitis delta virus infection on progression to" exact="cirrhosis" post="in chronic hepatitis type BJ Infect Dis155519879319353559292 7RomeoR.Del NinnoE.RumiM.A"/>
  <result pre="hepatitis delta virus infection on progression to cirrhosis in chronic" exact="hepatitis" post="type BJ Infect Dis155519879319353559292 7RomeoR.Del NinnoE.RumiM.A 28-year study of"/>
  <result pre="Infect Dis155519879319353559292 7RomeoR.Del NinnoE.RumiM.A 28-year study of the course of" exact="hepatitis" post="Delta infection: a risk factor for cirrhosis and hepatocellular"/>
  <result pre="the course of hepatitis Delta infection: a risk factor for" exact="cirrhosis" post="and hepatocellular carcinomaGastroenterology136520091629163819208358 8JiJ.SundquistK.SundquistJ.A population-based study of hepatitis D"/>
  <result pre="factor for cirrhosis and hepatocellular carcinomaGastroenterology136520091629163819208358 8JiJ.SundquistK.SundquistJ.A population-based study of" exact="hepatitis" post="D virus as potential risk factor for hepatocellular carcinomaJ"/>
  <result pre="for hepatocellular carcinomaJ Natl Cancer Inst10410201279079222423008 9MahaleP.AkaP.ChenX.Hepatitis D virus infection," exact="cirrhosis" post="and hepatocellular carcinoma in the GambiaJ Viral Hepat266201973874930661282 10TerraultN.A.LokA.S.F.McMahonB.J.Update"/>
  <result pre="carcinomaJ Natl Cancer Inst10410201279079222423008 9MahaleP.AkaP.ChenX.Hepatitis D virus infection, cirrhosis and" exact="hepatocellular carcinoma" post="in the GambiaJ Viral Hepat266201973874930661282 10TerraultN.A.LokA.S.F.McMahonB.J.Update on prevention, diagnosis,"/>
  <result pre="Viral Hepat266201973874930661282 10TerraultN.A.LokA.S.F.McMahonB.J.Update on prevention, diagnosis, and treatment of chronic" exact="hepatitis" post="B: AASLD 2018 Hepatitis B guidanceClin Liver Dis (Hoboken)1212018333430988907"/>
  <result pre="(fact sheet)Available at:https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-d2019Accessed November 22, 2019 12AragonaM.MacagnoS.CareddaF.Serological response to the" exact="hepatitis" post="delta virus in hepatitis DLancet1853119874784802881041 13WrankeA.HeidrichB.ErnstS.Anti-HDV IgM as a"/>
  <result pre="22, 2019 12AragonaM.MacagnoS.CareddaF.Serological response to the hepatitis delta virus in" exact="hepatitis" post="DLancet1853119874784802881041 13WrankeA.HeidrichB.ErnstS.Anti-HDV IgM as a marker of disease activity"/>
  <result pre="DLancet1853119874784802881041 13WrankeA.HeidrichB.ErnstS.Anti-HDV IgM as a marker of disease activity in" exact="hepatitis" post="deltaPLoS One972014e10100225072849 14Le GalF.BrichlerS.SahliR.First international external quality assessment for"/>
  <result pre="hepatitis deltaPLoS One972014e10100225072849 14Le GalF.BrichlerS.SahliR.First international external quality assessment for" exact="hepatitis" post="delta virus RNA quantification in plasmaHepatology64520161483149427530084 15TakyarV.SuranaP.KleinerD.E.Noninvasive markers for"/>
  <result pre="hepatitisAliment Pharmacol Ther451201712713827813124 16DaB.L.SuranaP.TakyarV.Vibration-controlled transient elastography for the detection of" exact="cirrhosis" post="in chronic Hepatitis D infectionJ Viral Hepat274202042843631742822 17HughesS.A.WedemeyerH.HarrisonP.M.Hepatitis delta"/>
  <result pre="delta virusLancet37897852011738521511329 18WedemeyerH.YurdaydìnC.DalekosG.N.Peginterferon plus adefovir versus either drug alone for" exact="hepatitis" post="deltaN Engl J Med3644201132233121268724 19WedemeyerH.YurdaydinC.HardtkeS.Peginterferon alfa-2a plus tenofovir disoproxil"/>
  <result pre="Engl J Med3644201132233121268724 19WedemeyerH.YurdaydinC.HardtkeS.Peginterferon alfa-2a plus tenofovir disoproxil fumarate for" exact="hepatitis" post="D (HIDIT-II): a randomised, placebo controlled, phase 2 trialLancet"/>
  <result pre="the LiverEASL 2017 clinical practice guidelines on the management of" exact="hepatitis" post="B virus infectionJ Hepatol672201737039828427875 21SarinS.K.KumarM.LauG.K.Asian-Pacific clinical practice guidelines on"/>
  <result pre="infectionJ Hepatol672201737039828427875 21SarinS.K.KumarM.LauG.K.Asian-Pacific clinical practice guidelines on the management of" exact="hepatitis" post="B: a 2015 updateHepatol Int1012016198 22ZachouK.YurdaydinC.DrebberU.Quantitative HBsAg and HDV-RNA"/>
  <result pre="23HeidrichB.YurdaydınC.KabaçamG.Late HDV RNA relapse after peginterferon alpha-based therapy of chronic" exact="hepatitis" post="deltaHepatology6012014879724585488 24GuedjJ.RotmanY.CotlerS.J.Understanding early serum hepatitis D virus and hepatitis"/>
  <result pre="peginterferon alpha-based therapy of chronic hepatitis deltaHepatology6012014879724585488 24GuedjJ.RotmanY.CotlerS.J.Understanding early serum" exact="hepatitis" post="D virus and hepatitis B surface antigen kinetics during"/>
  <result pre="chronic hepatitis deltaHepatology6012014879724585488 24GuedjJ.RotmanY.CotlerS.J.Understanding early serum hepatitis D virus and" exact="hepatitis" post="B surface antigen kinetics during pegylated interferon-alpha therapy via"/>
  <result pre="interferon therapy and outcomeClin Gastroenterol Hepatol1313201523422349.e1-226044319 26NiroG.A.SmedileA.FontanaR.HBsAg kinetics in chronic" exact="hepatitis" post="D during interferon therapy: on-treatment prediction of responseAliment Pharmacol"/>
  <result pre="Ther446201662062827443972 27SamuelD.ZignegoA.L.ReynesM.Long-term clinical and virological outcome after liver transplantation for" exact="cirrhosis" post="caused by chronic delta hepatitisHepatology21219953333397843702 28YurdaydinC.AbbasZ.ButiM.Treating chronic hepatitis delta:"/>
  <result pre="transplantation for cirrhosis caused by chronic delta hepatitisHepatology21219953333397843702 28YurdaydinC.AbbasZ.ButiM.Treating chronic" exact="hepatitis" post="delta: the need for surrogate markers of treatment efficacyJ"/>
  <result pre="32Kumar AcharyaS.Kumar SharmaP.SinghR.Hepatitis E virus (HEV) infection in patients with" exact="cirrhosis" post="is associated with rapid decompensation and deathJ Hepatol463200738739417125878 33NavaneethanU.Al"/>
  <result pre="associated with control of HEV infectionHepatology553201269570822006345 36KamarN.GarrousteC.HaagsmaE.B.Factors associated with chronic" exact="hepatitis" post="in patients with hepatitis E virus infection who have"/>
  <result pre="HEV infectionHepatology553201269570822006345 36KamarN.GarrousteC.HaagsmaE.B.Factors associated with chronic hepatitis in patients with" exact="hepatitis" post="E virus infection who have received solid organ transplantsGastroenterology140520111481148921354150"/>
  <result pre="transplantsGastroenterology140520111481148921354150 37FernandesB.DiasE.Mascarenhas-SaraivaM.Rheumatologic manifestations of hepatic diseasesAnn Gastroenterol324201935236031263357 38KamarN.MarionO.AbravanelF.Extrahepatic manifestations of" exact="hepatitis" post="E virusLiver Int364201646747227005692 39HaffarS.BazerbachiF.GargS.Frequency and prognosis of acute pancreatitis"/>
  <result pre="manifestations of hepatitis E virusLiver Int364201646747227005692 39HaffarS.BazerbachiF.GargS.Frequency and prognosis of" exact="acute pancreatitis" post="associated with acute hepatitis E: a systematic reviewPancreatology154201532132626049260 40CheungM.C.MaguireJ.CareyI.Review"/>
  <result pre="of hepatitis E virusLiver Int364201646747227005692 39HaffarS.BazerbachiF.GargS.Frequency and prognosis of acute" exact="pancreatitis" post="associated with acute hepatitis E: a systematic reviewPancreatology154201532132626049260 40CheungM.C.MaguireJ.CareyI.Review"/>
  <result pre="Int364201646747227005692 39HaffarS.BazerbachiF.GargS.Frequency and prognosis of acute pancreatitis associated with acute" exact="hepatitis" post="E: a systematic reviewPancreatology154201532132626049260 40CheungM.C.MaguireJ.CareyI.Review of the neurological manifestations"/>
  <result pre="E: a systematic reviewPancreatology154201532132626049260 40CheungM.C.MaguireJ.CareyI.Review of the neurological manifestations of" exact="hepatitis" post="E infectionAnn Hepatol115201261862222947521 41KamarN.WeclawiakH.Guilbeau-FrugierC.Hepatitis E virus and the kidney"/>
  <result pre="solid-organ transplant patientsTransplantation936201261762322298032 42HuangS.ZhangX.JiangH.Profile of acute infectious markers in sporadic" exact="hepatitis" post="EPLoS One5102010e1356021042408 43BaylisS.A.WallaceP.McCullochE.Standardization of nucleic acid tests: the approach"/>
  <result pre="cell-culture assayJ Gen Virol87Pt 3200669770416476993 46MalcolmP.DaltonH.HussainiH.S.The histology of acute autochthonous" exact="hepatitis" post="E virus infectionHistopathology512200719019417650215 47ProtzerU.BöhmF.LongerichT.Molecular detection of hepatitis E virus"/>
  <result pre="of acute autochthonous hepatitis E virus infectionHistopathology512200719019417650215 47ProtzerU.BöhmF.LongerichT.Molecular detection of" exact="hepatitis" post="E virus (HEV) in liver biopsies after liver transplantationMod"/>
  <result pre="Pathol284201552353225412844 48TeH.DoucetteK.Viral hepatitis: guidelines by the American society of transplantation" exact="infectious disease" post="community of practiceClin Transplant3392019e1351430817047 49UnzuetaA.RakelaJ.Hepatitis E infection in liver"/>
  <result pre="E infection in liver transplant recipientsLiver Transpl2012014152424123928 50BehrendtP.SteinmannE.MannsM.P.The impact of" exact="hepatitis" post="E in the liver transplant settingJ Hepatol61620141418142925195557 51HaagsmaE.B.Riezebos-BrilmanA.van den"/>
  <result pre="the liver transplant settingJ Hepatol61620141418142925195557 51HaagsmaE.B.Riezebos-BrilmanA.van den BergA.P.Treatment of chronic" exact="hepatitis" post="E in liver transplant recipients with pegylated interferon alpha-2bLiver"/>
  <result pre="transplant recipients with pegylated interferon alpha-2bLiver Transpl164201047447720373458 52KamarN.IzopetJ.TriponS.Ribavirin for chronic" exact="hepatitis" post="E virus infection in transplant recipientsN Engl J Med3701220141111112024645943"/>
  <result pre="transplant recipientsN Engl J Med3701220141111112024645943 53LiS.W.ZhaoQ.WuT.The development of a recombinant" exact="hepatitis" post="E vaccine HEV 239Hum Vaccin Immunother114201590891425714510 54NorvellJ.P.BleiA.T.JovanovicB.D.Herpes simplex virus"/>
  <result pre="published literature and institutional casesLiver Transpl131020071428143417902129 55LevitskyJ.DuddempudiA.T.LakemanF.D.Detection and diagnosis of" exact="herpes simplex" post="virus infection in adults with acute liver failureLiver Transpl141020081498150418825709"/>
  <result pre="virus infection in adults with acute liver failureLiver Transpl141020081498150418825709 56PattiM.E.SelvaggiK.J.KrobothF.J.Varicella" exact="hepatitis" post="in the immunocompromised adult: a case report and review"/>
  <result pre="report and review of the literatureAm J Med881199077802403757 57KusneS.PappoO.ManezR.Varicella-zoster virus" exact="hepatitis" post="and a suggested management plan for prevention of VZV"/>
  <result pre="transplantation infectious diseases community of practiceClin Transplant3392019e1351830844089 71DelyonJ.RabateC.EuvrardS.Management of Kaposi" exact="sarcoma" post="after solid organ transplantation: a European retrospective studyJ Am"/>
 </snippets>
</snippetsTree>
